BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2901683)

  • 21. Effects of a thioreactive agent, diamide, on neuromuscular transmission in lobster.
    Colton CA; Colton JS
    Am J Physiol; 1982 Jan; 242(1):C59-64. PubMed ID: 6277199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease in transmitter output and synaptic ultrastructure at lobster neuromuscular terminals with decentralization.
    Chiang RG; Govind CK
    Brain Res; 1984 May; 299(2):265-79. PubMed ID: 6145493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in synaptic transmission produced by hydrogen peroxide.
    Colton CA; Colton JS; Gilbert DL
    J Free Radic Biol Med; 1986; 2(2):141-8. PubMed ID: 3029210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.
    Hiltunen AJ; Järbe TU
    Neuropharmacology; 1986 Feb; 25(2):133-42. PubMed ID: 3010159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
    Brady KT; Balster RL
    Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
    Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
    Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimethaphan as a glutamate inhibitor at the crayfish neuromuscular junction.
    Shinozaki H; Ishida M
    Brain Res; 1983 Jun; 268(2):295-305. PubMed ID: 6135494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response.
    Baczynsky WO; Zimmerman AM
    Pharmacology; 1983; 26(1):1-11. PubMed ID: 6298841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes.
    Baczynsky WO; Zimmerman AM
    Pharmacology; 1983; 26(1):12-9. PubMed ID: 6298842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabimimetic activity (delta 1-THC cue) of cannabidiol monomethyl ether and two stereoisomeric hexahydrocannabinols in rats and pigeons.
    Järbe TU; Hiltunen AJ; Lander N; Mechoulam R
    Pharmacol Biochem Behav; 1986 Aug; 25(2):393-9. PubMed ID: 3020594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The action of serotonin on excitatory nerve terminals in lobster nerve-muscle preparations.
    Glusman S; Kravitz EA
    J Physiol; 1982 Apr; 325():223-41. PubMed ID: 6125589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptamine enhancement of neurotransmitter release under conditions that normally depress calcium influx.
    Friedman RN; Shank RP; Freeman AR
    Brain Res; 1986 Jan; 364(1):172-6. PubMed ID: 2868776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of delta 9-tetrahydrocannabinol, cannabidiol, and shock on plasma corticosterone concentrations in rats.
    Jacobs JA; Dellarco AJ; Manfredi RA; Harclerode J
    J Pharm Pharmacol; 1979 May; 31(5):341-2. PubMed ID: 37310
    [No Abstract]   [Full Text] [Related]  

  • 35. TI-233 as a glutamate channel blocker at the crayfish neuromuscular junction.
    Ishida M; Shinozaki H
    Br J Pharmacol; 1985 Sep; 86(1):105-16. PubMed ID: 2413933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cannabinoids on the activity of monoamine oxidase in normal human platelets.
    Mazor M; Dvilansky A; Aharon M; Lazarovitz Z; Nathan I
    Arch Int Physiol Biochim; 1982 Apr; 90(1):15-20. PubMed ID: 6179486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).
    Rock EM; Parker LA
    Behav Neurosci; 2015 Jun; 129(3):368-70. PubMed ID: 26030435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of delta9-tetrahydrocannabinol and cannabidiol on a Mg2+-ATPase of synaptic vesicles prepared from rat cerebral cortex.
    Gilbert JC; Pertwee RG; Wyllie MG
    Br J Pharmacol; 1977 Apr; 59(4):599-601. PubMed ID: 139957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of anticonvulsant cannabinoids on posttetanic potentiation at isolated bullfrog ganglia.
    Turkanis SA; Karler R
    Life Sci; 1975 Aug; 17(4):569-78. PubMed ID: 1081172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.